hexagons

Latest News

FORMA Therapeutics and the University of Oxford Announce Multi-Year Cross-Border Collaboration

FORMA Therapeutics and the University of Oxford Announce Multi-Year Cross-Border Collaboration

Posted 16/05/2018

The FORMA/Oxford collaboration brings together Oxford’s expertise in disease molecular pathology and Ubiquitin biology, (including through the Alzheimer’s Research UK Oxford Drug Discovery Institute (ODDI), the Target Discovery Institute (TDI) and the Oxford Parkinson’s Disease Centre (OPDC)), and FORMA’s deep expertise in small molecule drug design and development.

 

Using management thinking to fight the superbug crisis

Using management thinking to fight the superbug crisis

Posted 16/05/2018

Science blog by Dr Marco Haenssgen who discusses the application of management thinking to solving the growing global problem of antimicrobial resistance.

 

News Archive

Recent Publications

The Privacy and Security Implications of Open Data in Healthcare. Yearb Med Inform. Article

Implementing an Open Source Electronic Health Record System in Kenyan Health Care Facilities: Case Study. JMIR Med Inform, 6 (2), pp. e22. Article

Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows FRONTIERS IN IMMUNOLOGY, 9 (APR). Article

Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy. Sci Rep, 8 (1), pp. 5549. Article

A Pseudo-Kinase Double Act. Structure, 26 (4), pp. 527-528. Article

Publications Archive